Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association

Richard W. Nesto, David Bell, Robert O. Bonow, Vivian Fonseca, Scott M Grundy, Edward S. Horton, Martin Le Winter, Daniel Porte, Clay F. Semenkovich, Sidney Smith, Lawrence H. Young, Richard Kahn

Research output: Contribution to journalReview article

681 Scopus citations
Original languageEnglish (US)
Pages (from-to)2941-2948
Number of pages8
JournalCirculation
Volume108
Issue number23
DOIs
StatePublished - Dec 9 2003

Keywords

  • AHA Scientific Statements
  • Congestive heart failure
  • Diabetes mellitus
  • Drugs
  • Edema
  • Insulin
  • Thiazolidinediones

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Nesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., Young, L. H., & Kahn, R. (2003). Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association. Circulation, 108(23), 2941-2948. https://doi.org/10.1161/01.CIR.0000103683.99399.7E